Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke
Published: November 02, 2017
![Science News on light gray background](/-/media/PHD-Images/Science-News/science_news_default.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- While symptomatic intracranial hemorrhage (sICH) is uncommon, it is the most feared complication of intravenous thrombolytic therapy in acute ischemic stroke.
- Treatment of sICH is currently based on expert opinion or small observational studies.
- This scientific statement provides an overview of sICH, discussing pathophysiology and treatment options.
Supporting Materials
- Commentary: Intracranial Hemorrhage After Stroke Thrombolysis: More Questions Than Answers by Shyam Prabhakaran, MD, MS
- Top Things to Know: Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke
- Slide Set: Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in AIS (PDF)